Johnson Pharma

{
  "main_header": {
    "sid": 233635,
    "name": "Johnson Pharma",
    "stock_name": "Johnson Pharma",
    "full_name": "Johnson Pharmacare Ltd",
    "name_url": "stocks-analysis/johnson-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.53",
    "chg": -0.02,
    "chgp": "-3.64%",
    "dir": -1,
    "prev_price": "0.55",
    "mcapval": "30.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532154,
    "symbol": "",
    "ind_name": "Diversified Commercial Services",
    "ind_code": 49,
    "sector_id": 17,
    "indexname": "India SENSEX",
    "isin": "INE560F01022",
    "curr_date": "Jun 03, 03:30 PM",
    "curr_time": "01:33 AM",
    "last_traded_at": "Jun 03, 03:30 PM IST",
    "bse_nse_vol": "6.47 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 03, 2026",
    "traded_date_str": "2026 06 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/johnson-pharma-233635-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Johnson Pharmacare Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/johnson-pharmacare-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-4025236",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JohnsonPharmaca_mojoScore_4025236.png",
        "date": "2026-06-01 08:03:05",
        "description": "Johnson Pharmacare Ltd has been assigned a Strong Sell rating by MarketsMOJO as of 29 May 2026, reflecting deteriorating fundamentals and a bearish technical outlook. The downgrade from a previously ungraded status is driven by a comprehensive reassessment across quality, valuation, financial trend, and technical parameters, signalling heightened risk for investors in this micro-cap stock."
      },
      {
        "title": "Johnson Pharmacare Ltd Quality Grade Downgrade Highlights Fundamental Weaknesses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/johnson-pharmacare-ltd-quality-grade-downgrade-highlights-fundamental-weaknesses-4024917",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JohnsonPharmaca_qualitydot_4024917.png",
        "date": "2026-06-01 08:00:17",
        "description": "Johnson Pharmacare Ltd has recently undergone a significant downgrade in its quality grading, shifting from a non-qualifying status to a below average rating as of 29 May 2026. This change reflects deteriorating business fundamentals, particularly in profitability, capital efficiency, and financial stability, raising concerns for investors amid a challenging market backdrop."
      },
      {
        "title": "Johnson Pharmacare Q4 FY26: Alarming ₹55.61 Crore Loss Raises Serious Viability Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/johnson-pharmacare-q4-fy26-alarming-5561-crore-loss-raises-serious-viability-concerns-4022172",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JohnsonPharmaca_quaterlyResult_4022172.png",
        "date": "2026-05-29 17:04:35",
        "description": "Johnson Pharmacare Limited reported a catastrophic fourth quarter for FY26, posting a net loss of ₹55.61 crores in Q4 FY26—a dramatic deterioration from the ₹0.51 crore loss in Q4 FY25. The micro-cap diversified commercial services company, with a market capitalisation of just ₹30.00 crores, continues to generate zero revenue whilst accumulating substantial losses, raising fundamental questions about operational viability and business sustainability."
      }
    ],
    "total": 83,
    "sid": "233635",
    "stock_news_url": "https://www.marketsmojo.com/news/johnson-pharmacare-233635"
  },
  "announcements": [
    {
      "caption": "Outcome Of Meeting Of Board Of Directors Held On Wednesday 27Th May 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "01-Jun-2026",
      "details": "meeting of board of director to considered and approved the following 1.audited financial results 2. Statement of deviation or variation 3. take note on resignation of Rajendra prasad (Non- executive director) 4. take note on resignation of umesh kumar (executive director)",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "30-May-2026",
      "details": "Annual secretarial compliance report for the F.Y 31ST MARCH 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "28-May-2026",
      "details": "Submission of Extract of Newspaper Publication of Audited (Standalone) Financial Results for the quarter and year ended on 31st March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Johnson Pharmacare Ltd has announced <strong>1:10</strong> stock split, ex-date: 05 Jan 22",
          "dt": "2022-01-05",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Johnson Pharmacare Ltd has announced <strong>1:10</strong> bonus issue, ex-date: 07 Apr 22",
          "dt": "2022-04-07",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Johnson Pharmacare Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-06-01 08:03:05

Johnson Pharmacare Ltd has been assigned a Strong Sell rating by MarketsMOJO as of 29 May 2026, reflecting deteriorating fundamentals and a bearish technical outlook. The downgrade from a previously ungraded status is driven by a comprehensive reassessment across quality, valuation, financial trend, and technical parameters, signalling heightened risk for investors in this micro-cap stock.

Read full news article

Johnson Pharmacare Ltd Quality Grade Downgrade Highlights Fundamental Weaknesses

2026-06-01 08:00:17

Johnson Pharmacare Ltd has recently undergone a significant downgrade in its quality grading, shifting from a non-qualifying status to a below average rating as of 29 May 2026. This change reflects deteriorating business fundamentals, particularly in profitability, capital efficiency, and financial stability, raising concerns for investors amid a challenging market backdrop.

Read full news article

Johnson Pharmacare Q4 FY26: Alarming ₹55.61 Crore Loss Raises Serious Viability Concerns

2026-05-29 17:04:35

Johnson Pharmacare Limited reported a catastrophic fourth quarter for FY26, posting a net loss of ₹55.61 crores in Q4 FY26—a dramatic deterioration from the ₹0.51 crore loss in Q4 FY25. The micro-cap diversified commercial services company, with a market capitalisation of just ₹30.00 crores, continues to generate zero revenue whilst accumulating substantial losses, raising fundamental questions about operational viability and business sustainability.

Read full news article

View All News